ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

43,890Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 1448

$3.05M Total Retail Price of All Prescriptions

Rank: 5 out of 1448

723 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 723 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 41,769 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

61 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ALENDRONATE SODIUM 1,549 1,492 1 41
ATORVASTATIN CALCIUM 1,349 1,271 2 4
SIMVASTATIN 1,191 1,133 3 3
ZOLPIDEM TARTRATE 1,180 1,111 4 34
DIOVAN HCT 1,159 1,100 10 5 29
TAMSULOSIN HCL 1,142 1,112 6 46
NEXIUM 953 882 7 49
CRESTOR 909 850 8 17
OMEPRAZOLE 896 862 9 23
ATENOLOL 809 758 10 12
PRAVASTATIN SODIUM 790 729 11 20
CARVEDILOL 786 742 12 1
AMLODIPINE BESYLATE 760 732 13 2
DIOVAN 720 706 14 15
TRAMADOL HCL 701 671 15 56
LISINOPRIL 672 626 16 5
SERTRALINE HCL 667 652 17 99
MELOXICAM 654 597 18 73
LEVOTHYROXINE SODIUM 644 570 19 21
LOSARTAN-HYDROCHLOROTHIAZIDE 581 551 20 38
METOPROLOL TARTRATE 567 554 21 9
LOVAZA 527 500 22 39
PAROXETINE HCL 500 468 23 121
GABAPENTIN 496 469 24 51
JANUMET 496 472 24 119
DONEPEZIL HCL 489 489 26 68
VOLTAREN 487 479 27 107
CELEBREX 448 444 28 77
DEXILANT 445 410 29 87
LIPITOR 435 419 30 30
METFORMIN HCL 426 364 31 25
METOPROLOL SUCCINATE 419 394 32 6
CYMBALTA 414 395 33 123
FUROSEMIDE 413 398 34 7
CLOPIDOGREL 376 368 35 10
GLIMEPIRIDE 344 315 36 66
PRAMIPEXOLE DIHYDROCHLORIDE 321 306 37 217
PLAVIX 314 305 38 14
SPIRIVA 294 284 39 97
JANUVIA 291 291 40 64
PANTOPRAZOLE SODIUM 290 271 41 42
GLYBURIDE-METFORMIN HCL 287 287 R 42 132
MIRTAZAPINE 275 264 43 181
DICLOFENAC SODIUM 270 259 44 171
HYDROCODONE-ACETAMINOPHEN 257 232 S3 45 33
LYRICA 247 246 46 159
AMIODARONE HCL 243 243 47 22
BENICAR 243 235 47 50
NAMENDA 239 232 49 93
EXFORGE 233 222 50 80
ISOSORBIDE MONONITRATE ER 224 224 51 16
IBUPROFEN 224 210 51 85
MECLIZINE HCL 224 220 51 108
AZITHROMYCIN 222 206 54 76
ALLOPURINOL 222 222 54 43
NATEGLINIDE 214 211 56 160
CLONIDINE HCL 208 198 57 45
ESCITALOPRAM OXALATE 208 164 57 122
FLUOCINONIDE 208 195 57 144
SINGULAIR 206 200 60 91
AVODART 202 202 61 120
LANSOPRAZOLE 190 189 62 165
ATELVIA 185 163 63 157
LABETALOL HCL 183 183 64 100
PROLIA 178 173 10 65 273
ZETIA 178 175 65 28
HYDROCHLOROTHIAZIDE 174 160 67 18
ALCOHOL PREP PADS 171 148 68 278
ADVAIR DISKUS 168 161 69 74
LOSARTAN POTASSIUM 165 165 70 11
BENICAR HCT 159 159 71 84
SYMBICORT 156 147 72 208
ACTONEL 154 149 73 117
WARFARIN SODIUM 153 153 74 8
ACTOS 152 145 75 92
FENOFIBRATE 148 142 76 54
PROPRANOLOL HCL 147 142 77 105
FAMOTIDINE 141 139 78 60
POTASSIUM CHLORIDE 140 140 79 19
AMLODIPINE BESYLATE-BENAZEPRIL 139 139 80 67
LIDODERM 139 139 80 81
EFFIENT 139 139 80 69
LANTUS 138 114 83 111
METHOTREXATE 137 137 84 303
LEVOFLOXACIN 137 128 84 131
SULINDAC 136 130 86 264
CILOSTAZOL 136 136 86 95
TRICOR 132 132 88 94
NAPROXEN 128 118 89 112
VESICARE 120 120 90 205
PROAIR HFA 119 110 91 104
FLECTOR 116 114 92 242
ACIPHEX 115 112 93 174
MEGESTROL ACETATE 115 113 R 93 126
LEXAPRO 114 108 95 163
QUETIAPINE FUMARATE 113 113 96 223
THEOPHYLLINE ANHYDROUS 112 112 97 225
MONTELUKAST SODIUM 111 107 98 135
OXYBUTYNIN CHLORIDE ER 106 98 99 281
BENAZEPRIL HCL 106 90 99 26
INSULIN SYRINGE 105 82 101 139
RAMIPRIL 104 94 102 36
TRIAMCINOLONE ACETONIDE 104 103 102 96
FLUOXETINE HCL 89 79 104 164
ALCOHOL SWABS 88 62 105 333
VALSARTAN-HYDROCHLOROTHIAZIDE 87 82 106 212
PRADAXA 86 86 107 27
COLCRYS 86 86 107 183
CLOTRIMAZOLE 86 84 107 334
DETROL LA 85 85 110 236
SOLARAZE 85 81 110 337
PATADAY 84 84 112 207
IBANDRONATE SODIUM 83 74 113 148
NASONEX 79 78 114 155
TRIAMTERENE-HCTZ 76 70 115 55
PRANDIN 76 73 115 225
SURE COMFORT 74 65 117 240
CARBIDOPA-LEVODOPA 72 72 118 227
DOXAZOSIN MESYLATE 70 70 119 65
COREG CR 70 69 119 83
SYNTHROID 70 67 119 90
DIGOXIN 69 69 122 13
BONIVA 67 55 123 167
ACETAMINOPHEN-CODEINE 65 64 S3 124 113
HYDROXYZINE HCL 65 64 R 124 195
NOVOLIN 70-30 65 51 124 305
CIPROFLOXACIN HCL 65 62 124 137
TERAZOSIN HCL 64 58 128 116
CITALOPRAM HBR 63 62 129 129
VYTORIN 63 62 129 71
TEKTURNA 62 62 131 106
KETOCONAZOLE 62 55 131 204
METOCLOPRAMIDE HCL 59 59 133 190
SURE COMFORT ALCOHOL 59 59 133 373
SEROQUEL 58 58 135 268
DIPHENOXYLATE-ATROPINE 56 54 136 297
SUCRALFATE 56 55 136 220
GLIPIZIDE 55 55 138 75
DILTIAZEM 24HR CD 54 54 139 61
GLYBURIDE 53 53 R 140 89
BETAMETHASONE DIPROPIONATE 53 44 140 281
DICYCLOMINE HCL 52 52 142 248
MICARDIS HCT 52 49 142 185
LEVEMIR FLEXPEN 51 51 144 307
FLUTICASONE PROPIONATE 50 50 145 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.